Arcellx (ACLX) Net Margin Growth (1y) (2024 - 2025)

Arcellx (ACLX) Net Margin Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,491.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -653.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -313,335.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -313,335.00
Sep 30, 2025 -102,774.00
Jun 30, 2025 -59,517.00
Mar 31, 2025 -74,769.00
Dec 31, 2024 -33,959.00
Sep 30, 2024 16,362.00
Jun 30, 2024 6,748.00
Mar 31, 2024 13,432.00